Akorn (AKRX) Agrees to Settlement with FTC in Proposed Acquisiton of VersaPharm
Tweet Send to a Friend
Pharmaceutical company Akorn, Inc. (Nasdaq: AKRX) has agreed to sell its rights to develop, manufacture, and market the generic injectable ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
